Covered recipient · General Payments record
PHILIP PERERA
General Payments · PY2019–2020
$40,585.30
- Reported across 15 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $21,736.30 | 12 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Sage Therapeutics, Inc. | $21,736.30 | 12 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (12)
Sorted by paying entity, then date · as published by CMS
Program year 2020 2019
Record-level detail is published for PY2020; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Sage Therapeutics, Inc. | $2,234.70 | 04/03/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040319 | CMS |
| Sage Therapeutics, Inc. | $1,849.47 | 04/10/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040321 | CMS |
| Sage Therapeutics, Inc. | $1,257.58 | 04/17/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040323 | CMS |
| Sage Therapeutics, Inc. | $1,560.56 | 04/24/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040325 | CMS |
| Sage Therapeutics, Inc. | $479.30 | 05/01/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040327 | CMS |
| Sage Therapeutics, Inc. | $868.60 | 05/08/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040329 | CMS |
| Sage Therapeutics, Inc. | $3,082.82 | 05/22/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040331 | CMS |
| Sage Therapeutics, Inc. | $2,802.79 | 05/29/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040333 | CMS |
| Sage Therapeutics, Inc. | $1,945.78 | 06/05/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040335 | CMS |
| Sage Therapeutics, Inc. | $1,753.16 | 06/12/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040337 | CMS |
| Sage Therapeutics, Inc. | $2,437.31 | 06/19/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040339 | CMS |
| Sage Therapeutics, Inc. | $1,464.23 | 06/26/2020 | Consulting Fee | Undisputed | 01/23/2026 | 749040341 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020
- Source files
- Dataset page · Bulk file · PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.